Cardio Diagnostics Holdings Inc
CDIOW0.030USD
-0.009-23.86%
Close 04/25, 16:00（ET）Quotes delayed by 15 min
--Market Cap
--P/E TTM
More Details of Cardio Diagnostics Holdings Inc Company
Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development, and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.
Company Info
Company codeCDIOW
Company nameCardio Diagnostics Holdings Inc
IPO dateNov 23, 2021
Founded at2021
CEODr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Number of employees- -
Security typeCompany Warrant
Fiscal year-end- -
Address311 W. Superior Street
CityCHICAGO
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code60645
Phone18552269991
Website
Company codeCDIOW
IPO dateNov 23, 2021
Founded at2021
Company Executives
Name
Name/Position
Position
Shareholding
Change
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--
Mr. Paul Burton, J.D.
Mr. Paul Burton, J.D.
Independent Director
Independent Director
--
--
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
--
--
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
--
Mr. Paul Burton, J.D.
Mr. Paul Burton, J.D.
Independent Director
Independent Director
--
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--
Mr. Paul Burton, J.D.
Mr. Paul Burton, J.D.
Independent Director
Independent Director
--
--
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholder
Update time: Wed, Apr 2
Update time: Wed, Apr 2
Shareholder Statistics
Type
Shareholder Statistics
Shareholder
Proportion
Other
100.00%
Shareholder Statistics
Shareholder
Proportion
Other
100.00%
Type
Shareholder
Proportion
Other
100.00%
Institutional Shareholding
Update time: Mon, Mar 3
Update time: Mon, Mar 3
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
21
580.02K
0.00%
-815.90K
2024Q4
27
580.02K
0.00%
-1.17M
2024Q3
29
968.76K
0.00%
-800.56K
2024Q2
31
932.85K
0.00%
-1.50M
2024Q1
31
1.20M
0.00%
-1.20M
2023Q4
31
1.25M
0.00%
-1.14M
2023Q3
31
1.30M
0.00%
-1.11M
2023Q2
31
1.31M
0.00%
-1.11M
2023Q1
31
1.36M
0.00%
-1.02M
2022Q4
28
1.68M
0.00%
-569.48K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
DoubleLine Capital LP
--
0%
-11.64K
-100.00%
Mar 31, 2024
Virtu Americas LLC
--
0%
-14.51K
-100.00%
Jun 30, 2024
Walleye Trading, LLC
--
0%
-132.26K
-100.00%
Dec 31, 2024
RiverNorth Capital Management LLC
--
0%
-39.83K
-100.00%
Mar 31, 2024
AQR Arbitrage, LLC
--
0%
-2.79K
-100.00%
Dec 31, 2023
Susquehanna International Group, LLP
--
0%
-25.99K
-100.00%
Jun 30, 2024
Castle Creek Arbitrage, LLC
--
0%
-11.71K
-100.00%
Sep 30, 2023
Citadel Advisors LLC
--
0%
-11.63K
-100.00%
Dec 31, 2024
UBS Financial Services, Inc.
--
0%
-9.74K
-100.00%
Dec 31, 2024
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data